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Executive Summary
Problem Statement
The Prostate Cancer Screening Program at the Markey Cancer Center co-sponsors prostate cancer
screenings with the Prostate Cancer Education Council. All participation, including African-American
attendance, has decreased 38% from years 2006 to 2008 and program managers are seeking insight to
improve program participation by acquiring knowledge of behavioral and medical characteristics that
may influence screening attendance. Because of the higher incidence of prostate cancer in AfricanAmerican men (ACS, 2008), a specific program goal is also to increase screening attendance for this
minority population.

Research Strategy
Questions that assess participant behavior, personal, and family medical history are analyzed to
determine specific relevant variables that may influence participation. A general description of the data
and participation rates, for new and returning participants, is presented. Variable analysis will be
conducted for certain behavioral factors and grouped variable analyses will be conducted for urinary,
sexual and testosterone health symptoms. Relevant variables with predict returning participant
behaviors.

Major Findings
Personal and family health histories play an important role in participation. Men who consider
themselves high risk are more likely to smoke, and returning participant models found that men with
these variables are more likely to return. Returning African-American behavior is largely unknown
although a small portion of men are suffering from testosterone health symptoms. Sexual health
symptoms play an important role in the overall attendance of African-American men. Urinary health
symptoms do not play an important role in the attendance of program participants. This might be
unfortunate, considering that urinary symptoms are more relevant to prostate cancer than sexual health
symptoms. There are no statistically significant differences related to race, but this is a policy problem,
given that African-American’s are more likely to have prostate cancer.
Most participants report receiving information about the program via: newspaper, friends and family,
and by radio and television. Program managers can use the findings about behavioral and medical
factors that affect participation to develop targeted marketing strategies. Marketing avenues that are
effective and have not been explored are places of work and wives or significant others.

Recommendations
It is recommended that program managers should focus marketing efforts on men with sexual and
testosterone health symptoms, those who believe they are at high risk for prostate cancer to encourage
retention. A special marketing effort towards African-Americans is essential in realizing program goals.
Program managers should strategize marketing efforts via newspaper, radio, television, and the
internet. Different motives underlie decisions to seek or return for screening including: high risk, health
consciousness, and pressure from a wife, and marketing initiatives could target all of these. Greater
success in attracting returning African-Americans would be relevant and is not, at present, occurring.
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I. Background and Relevant Facts
A. Program Background
This research paper reports findings from a survey given to prostate
screening attendees at the Markey Cancer Center (Markey). Data from 2006-2008
were analyzed to identify factors, relationships, and trends in the behavior of both
returning and new participants in the prostate cancer screening program. The goal
of the research is to develop information that is useful to program managers,
administrators, and grant givers in an effort to continue the program and increase
attendance.
Organizations, such as the Prostate Cancer Education Council (PCEC) cosponsor prostate cancer screenings to encourage early detection methods. Prostate
cancer screenings at the Markey Cancer Center are held in conjunction with Prostate
Cancer Awareness Week (PCAW), a national program coordinated by the PCEC. The
PCEC currently has more than 600 research screening sites, and since its inception in
1989, has screened more than 3,000,000 men (PCEC, 2009).
PCAW is usually held in September, and Markey operates two (2) additional
screening programs annually in April and December. Program participation is open
for all Kentucky residents. The Kentucky Cancer Program, in conjunction with the
University of Kentucky, runs the program and pays for nearly half of the program
expenses with grant monies received from Toyota Motor Manufacturing. The grant
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is currently managed by the Markey Cancer Foundation. To keep expenses low, the
benefit of participating in the PCEC co-sponsored screening is that of discounted lab
costs for Prostate Specific Antigen exams (PSA).
Currently, program managers advertise the program on local radio and
televisions stations, in community newspapers, and on the UK HealthCare and PCEC
websites. Analyses presented here will help target marketing efforts to improve
program participation, specifically for African-American men. Under the direct
supervision of the PCEC, Markey meets HIPPA and Internal Review Board (IRB)
compliance for the study. However, targeting men for the program continues to
need improvement.
In the state of Kentucky various initiatives are in place to encourage early
detection and education about prostate cancer health. There are four cancer
centers that participate in free or reduced cost prostate cancer screening programs:
the University of Kentucky’s Markey Cancer Center (Markey), the Jennie Stuart
Medical Center in Hopkinsville, the Leonard Lawson Cancer Center located in
Pikeville, and the James Graham Brown Cancer Center in Louisville. Geographically,
Markey is the only Central Kentucky participating partner with the PCEC program.
Currently, three out of four screening sites in Kentucky participate in the
PCEC co-sponsored longitudinal study; however, data are only available from
Markey. A longitudinal study is a research study that extends for several years and is
often aimed at developing conclusive evidence for policy makers. The program’s
2

mission is to screen and educate Kentucky’s men about the warning signs, health
hazards, and treatment options of prostate cancer. There are 5 initiatives for the
2009 grant:
1. Provide education and instill awareness across the entire regional service
area concerning prostate cancer, overall health and wellness, and the
possibility and importance of early prostate cancer detection.
2. Provide specific opportunities for prostate cancer screening at no financial
cost to participants.
3. Increase minority participation.
4. Maintain quality of current program.
5. Increase early detection rates, cure and quality of life.
Grant objectives are to improve attendance year after year, specifically for
minority populations. Funding for cancer research, education, and screening has
long been promoted by private and public donation. The most recent statistics by
the PCEC estimate that that prostate cancer programs are underfunded and
currently for every $100 donated to breast cancer only $1 is given to prostate cancer
health and research programs. However Markey has been successful in seeking
funding.
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B. Relevant Facts
Prostate cancer is the second leading cause of cancer death after lung cancer
for men and is the second most common cancer after skin cancer (PCEC, 2008).
Several years ago statistics estimated that prostate cancer would strike one in
eleven males during their lifetime (PCEC, 2008). Today, it’s one in six, and the
American Cancer Society (ACS) predicts that 1 in 35 men or 28,660 will die of this
disease in 2008 (ACS, 2009). Screening already plays a key role in the management
of cervical and breast cancer, and is likely to become more important in the control
of colorectal, prostate and lung cancer (ACS, 2009).
Prostate cancer isn’t just a burden emotionally or physically—it’s a burden
financially. CANCER, a peer-reviewed journal for the American Cancer Society
published a study that estimates the cumulative cost for prostate cancer at $42,570
for five years, (Wilson, 2006) and individual out-of-pocket cost for other types of
cancer survivors on average at $8,900 (Harrington, 2009). Based on US Medicare
data, the cost per life year saved by the two most popular prostate cancer screening
mechanisms, the PSA and the Digital Rectal Exam (DRE), compared with no
screening was $12,502-$15,213 for men aged 65, $27,075 in men aged 70, and
$41,672-$55,681 in men aged 75 (Barry, 1995).
Economic issues play an important role in medical decision-making, and are
just as important in prostate cancer screenings (Imamura, 2008). The importance of
the program is not only justified because of its ability to save lives but also the
4

economic and societal impact prostate screening can have on the community.
Because identifying prostate cancer early provides men the best chance of survival
and financial freedom, early detection represents one of the most promising
approaches in reducing the growing cancer burden (Etzioni, 2003).
“The promise for early detection is that it will identify cancer while still
localized and curable, preventing not only mortality, but reducing morbidity and
costs.” (Etzioni, 2003). More than 2 million men in the United States who have had
prostate cancer at some point are still alive today (ACS, 2009). According to the ACS,
the death rate for prostate cancer has decreased, and if detected early, prostate
cancer is considered highly curable. In fact, ACS also reports that the 5-year survival
rate of men with prostate cancer detected in the earliest stages is 100% (PCEC,
2008). Screening serves as an early detection tool as 79% of all prostate cancers are
discovered in their local and regional stages have a 5-year survival rate of 100%, and
according to more specific data, 67% of men diagnosed with prostate cancer survive
10 years and 52% survive for 15 years (ACS, 2009).
Although prostate cancer mortality rates declined 4.4% among men
nationally from years 2001 to 2005 (Rabin, 2008), prostate cancer incidence among
African-American men remains more than twice as high among white men (ACS,
2008). Markey realizes the need to encourage the screening of African-American
men, and specific program initiatives are being put in place to increase all minority
screenings in 2009 (MCF, 2009). African-Americans are more likely to be diagnosed
5

with advanced stage diseases for breast, cervical, colorectal, lung, prostate, and
ovarian cancers and men who have a longer time between doctor’s visits have
poorer survival rates (Wade, 2008) and substantial long-term prostate-related
expenditures (Medical News Today, 2006).
Research shows that prostate cancer is disproportionately prevalent among
African-American men. Average incidence of prostate cancer is 60% higher in
African-American men when compared to white men, and African-American’s have
the highest mortality rate of any ethnic or racial group. (Crowford, 2003).
Additionally, African-American men who have a family history of prostate cancer
have a 75-80% higher risk of developing prostate cancer (Catalona, 2002). In fact,
over twice as many African-American men are diagnosed with prostate cancer, and
more than twice as many die from the disease (PCEC, 2009).
The relationship between prostate cancer incidence and African-American
men proves to be important to prostate cancer screening programs, as there is also
discussion that the financial burden of prostate cancer is more significant for
African-Americans as they are more often lower on the socio-economic ladder and
are more likely to be uninsured or underinsured. A lack of health insurance serves
as an influence in screening decisions (Cancer Council, 2009), and the free prostate
cancer screening program may be a solution for prostate cancer screenings for
lower-income men.
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According to the Kaiser Foundation, the uninsured rate of non-elderly
African-American’s is 21% compared with 17% for the population as a whole (Wade,
2008). Currently, Markey’s prostate screening program has remained flat in
targeting African-American men, as from years 2006 to 2008 screenings recruited
nearly 7.3% of African-Americans, while according to the 2000 census the state of
Kentucky’s African-American population is 7.7%. There is no statistically significant
difference between population proportions and screening proportions, but the
higher incidence of prostate cancer in African-Americans implies that the screening
rate should be higher in this group. The program is currently seeing a decrease of
almost 38% in attendance of all men, and program managers are looking for insights
into how to improve participation.
C. General Data Description
The program had a total of 1,019 participants comprised of 945 non AfricanAmerican participants and 74 African-American participants from years 2006 to
2008.
Chart 1: Total Participation, New versus Returning 2006-2008
2006
All Participants
African-American Participants
Total Participation
Return %
New %
African-American Participation
Return %
New %

Returning
258
20

New
136
10
394
65%
35%
30
66%
33%

2007
Returning
220
14
378
58%
42%
24
58%
41%

New
158
10

2008
Returning
178
8

Total
New
69
12

1,019
74

247
73%
27%
20
40%
60%
*Source: PCEC 2008.
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Total participation has fallen year over year from 2006 to 2008. Total
participation was at 394 participants in 2006, 378 in 2007, and 247 in 2008. Total
program participation has decreased 38% from years 2006-2008. Of those
participants, the percentage of returning participants from 2006 to 2008 was 65% in
2006, 58% in 2007 and 73% in 2008. Although 2008 had a record returning
participant year of nearly 73%, total new participation dropped nearly 30% from
2006 to 2008.
The specific data for African-American men followed a similar pattern. There
was a 44% drop in total participation from 30 in 2006 to 20 in 2008. Although the
number of new participants grew by nearly 45%, there was a decrease in returning
African-American participants by 65%.
The most common age group for participation was 61-70 for all participants
(Chart 1) and between ages of 51-60 for African-American men. The majority of
total participation among men older than 51 years of age, but African-American
participants are generally younger than the majority of other participants.
Chart 1: Participant’s Age 2006-2008

*Source PCEC 2009
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The most common way that participants learned about the program, as 3year averages report (Chart 2) was by two popular methods: friends and family and
the newspaper.
Chart 2: How did you hear about the screening, all participants 2006-2008

*Source PCEC 2009

There was little difference in the results between new and returning participants,
although the source of receiving word of the program via work plays an important
role for returning participants, and radio and television play an important role in
drawing new participants (Chart 3) and specifically African-American men (Chart 4).
Chart 3: How did you hear about the screening,
returning vs. new participants 2006-2008

*Work variable was tracked in 2007 & 2008 only

*Source PCEC 2009
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Chart 4: How did you hear about the screening,
African-American Participants 2006-2008

*Work variable tracked only in 2006 & 2007

*Source: PCEC 2009

It is important to note that the work variable was only tracked in 2007 and 2008, and
it can be reasonably predicted that it would have been important in 2006. The
“other” category appears to be a strong third, but due to a lack of specifics, that
method of program marketing was eliminated from this analysis.

II. Research Design
Panel data or data that follows the participant through a series of methodical
questions over multiple time periods helped me examine medical and behavioral
factors that may encourage program attendance. Behavioral and medical factors
will include attendance rationale, health implications, family cancer incidence, and
the feeling of being at high risk for prostate cancer. Medical factors include whether
men are currently suffering from urinary, sexual and testosterone health symptoms
and will also record if they are obese (tracked by participant’s BMI). Participant
models was developed using a statistical regression from relevant variables.
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Data will be analyzed for behavioral and medical differences in returning
versus new participation, and for African-American men specifically. For research
clarification, a new participant in 2008 did not participate in 2007 or 2006, a new
participant in 2007 did not participate in 2006, and a new participant in 2006 did not
participate in 2005. Data collected from PCEC patient-doctor questionnaires will be
statistically analyzed to estimate medical and behavioral characteristics in an
attempt to uncover attendance rational and to give managers better participant
understanding. Theses medical and behavioral factors will then predict future
participation models for new and returning program attendees.
Specific assessments will be made for behavioral questions, while grouped
medical factor analyses will be made for urinary, sexual and testosterone symptom
evaluations. Specific assessments will address each factor for significance. Grouped
assessments will group responses to track individuals who are feeling one or more
symptoms on an index of suffering from urinary, testosterone or sexual health
problems. Analyses are split between returning and new participants to analyze
differences. The following hypothesis and research questions will be addressed:
A. Hypothesis:
There are several medical and behavioral factors that contribute to participation in
the prostate cancer screening program including the feeling of being at high risk and
being health conscious. Participants with a family history of prostate cancer and
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personal health status as related to urinary, sexual, and testosterone health
symptoms are more likely to attend the program.
Research Questions:
What behavioral factors influence the decision for men to attend a
screening?
What medical factors influence the decision for men to attend a screening;
including family, personal medical history and current urinary, sexual and
testosterone health issues?
What do participants feel categorizes them as “high risk”? Does smoking
influence this assumption?
Are there specific behavioral and medical factors for African-American men?
What factors affect participation?
What factors can program managers use to improve and expand the
program?
Assessments will be made in the following ways:
1. Behavioral characteristics- will specifically assess participant behavior and
lifestyle indicators for attending the screening, current personal health
status, and family medical history. The analysis will use regression to
estimate the effect of relevant factors of new versus returning participants.
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These are discrete or categorical variables. Percentages will describe the
relevance of personal and family health history, and incidence of smoking
regarding those who identify themselves as high-risk candidates. A factor
analysis will also be completed to estimate reason attended.
2. BMI test- will specifically assess participants BMI as a lifestyle indicator to
predict the difference between new and returning program participants.
3. Urinary Symptoms Evaluation- will be grouped to assess if the participant is
suffering from urinary symptoms as a possible reason of attending the
screening. A participant will be characterized as “suffering from symptoms”
if a problem occurs at least half or more than half of the time, if they are
urinating more than three times a night, and if they are dissatisfied with their
urinary condition. Using factor analyses to summarize the indicators, the
analysis estimates if there is a relationship between suffering from urinary
symptoms and attending the screening.
4. Sexual Health Inventory- will be grouped to assess if the participant is
suffering from sexual health issues as a possible reason for attending the
screening. A participant will be characterized as “suffering from symptoms”
if a symptom occurs at least half or more than half of the time, if they have
low confidence in an erection, have difficulty or if they do not attempt
intercourse. Factor analyses will summarize the conditions.
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5. Testosterone Test- survey questions will be grouped to assess if the
participant is suffering from testosterone health issues as a possible reason
of attending the screening. A participant will be characterized as “suffering
from symptoms” if a response of “yes” is marked for any or all of the
questions. Factor analyses will summarize the conditions.
6.

Participant Models- will analyze variables found in the above tests in a
regression to predict future new and returning participant behavior.
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Responses to the following questionnaire are used in analysis:
1. GENERAL DATA DESCRIPTION
Age
What race/ethnicity best describes you?
Years participated in PCAW?
How did you hear about the free screening during Prostate Cancer Awareness Week?
2. BEHAVIORAL INVENTORY
Do you smoke or have you been a smoker?
What health conditions or procedures do you/have you had?
What is your family health history?
Why are you attending this screening program?
3. MEDICAL INVENTORY- BMI CALCULATION
4. MEDICAL INVENTORY- URINARY SYMPTOMS EVALUATION
How long after you had a sensation of not emptying your bladder completely after you finish urinating?
How often have you had to urinate again less than two hours after you finish urinating?
How often have you found that you stopped and started again several times when you urinate?
How often have you found it difficult to postpone urination?
How often have you had a weak urinary stream?
How often do you push or strain to begin urination?
If you spent the rest of your life with your urinary condition just the way it is now, how would you feel?
5. MEDICAL INVENTORY- SEXUAL HEALTH INVENTORY
How do you rate your confidence that you could get and keep an erection?
When you had erections with sexual stimulation, how often were your erections hard enough for
penetration (entering your partner)?
During sexual intercourse, how often were you able to maintain your erection after you had penetrated
(entered) your partner?
During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse?
6. MEDCIAL INVENTORY- LOW TESTOSTERONE TEST (FY ’08 % ’09 only)
Do you have a decrease in libido (sex drive)?
Do you have a lack of energy?
Do you have a decrease in strength and/or endurance?
Have you lost height?
Have you noticed a decreased "enjoyment in life"?
Are you sad and/or grumpy?
Are your erections less strong?
Have you noticed a recent deterioration in your ability to play sports?
Are you falling asleep after dinner?
Has there been a recent deterioration in your work performance?
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III. Analysis, Findings and Limitations
This research study focuses on assessing participant behavior related to their
medical history, family health history, and any personal reasons for attending the
screening. Analysis and findings will report on the success of current marketing and
outreach methods, a participant’s behavioral and medical reasons for attending the
screening, and their BMI as a lifestyle indicator.
A. Behavioral Factors:
Behavioral factors will address a participant’s lifestyle through variables, such
as their amount of exercise per week, amount of fat in their diet, smoking, and
current health problems. Some of these behaviors are also variables in the
predictive returning participant models discussed later in the analysis. As displayed
in Table 3, most participants have a diet medium in fat (Chart 5), do not smoke
(Chart 7) and exercise 2-3 times per week (Chart 10). Interestingly, the incidence of
participant smoking is nearly 32%, a higher percentage than the current state of
Kentucky’s average at 28.3% (WebMD, 2009).
Table 3: Current Participant Behavior 2006-2008
Behavior
Diet Medium in Fat
Do Not Smoke
Exercise 2-3 times per week

Frequency
74%
74%
42%

16

Current African-American behavior and general participant behavior match
show nearly identical results based on their amount of fat in diets, smoking and
frequency of exercise although more than 12% of African-American men had a diet
high in fat nearing over 2 times that of the average in the entire dataset of fat in diet
at 6% (Chart 6).
Table 4: Current African-American Participant Behavior 2006-2008
Behavior
Diet Medium in Fat
Do Not Smoke
Exercise 2-3 times per week

Frequency
72%
78%
42%

A participant’s personal and family medical history provides insight into the
rationale behind attendance. Participants, as a whole, commonly suffer from high
cholesterol and high blood pressure—two very common health conditions (Medicine
Net, 2009). It is important to note that there are several factors that follow with
relatively high incidence such as: enlarged prostate, prostate infection, erectile
dysfunction, heart disease, and type 2 diabetes (Chart 11). Health conditions
specific to African-Americans follow similarly (Chart 12) with the exception that
African-American men had a significantly higher rate of diabetes at 20.3% compared
to the dataset at 7.8%. Specific health symptoms for urinary, sexual, and
testosterone problems will be assessed for attendance relevance in the medical
section below.
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The last behavioral factor assessed was the reason the men attended the
screening. Overwhelmingly, new and returning participants (Chart 15 & 16)
attended the screening because they wanted to be certain they did not have
prostate cancer for both all participants and for African-American men specifically.
The second most popular attendance reason was the factor I am very health
conscious. Although the other factors remain somewhat level in relationship to each
other, African-American men had a large portion of nearly 30% of total attendees
declare they were at high risk compared with total participation at 11% (Chart 15 &
16), and mostly they were returning participants.
A factor analysis of reasons for attending indicates there may be several
different motivations and influences for attending. The strongest factor will have
the highest numerical weight for each variable in Table 5. The first (strongest) factor
is high risk (and family history) without a desire for certainty; this is a well-informed
group seeking testing. The second factor is general health consciousness. The third
factor is a combination of high risk and desire for certainty, and the fourth is wife’s
encouragement. The existence of different factors implies a need for different
advertising to reach differently motivated men. The certainty some seek cannot be
promised, of course, but advertising can target high risk men, health conscious men,
and wives.
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Table 5: Factor Analysis of Reason Attended 2006-2008
Variable
Factor 1
Factor 2
Factor 3
Factor 4
I think I am at high risk
*0.3808
-0.0498
*0.1245
-0.0410
My wife encouraged me to attend
0.0834
-0.1467
-0.2013
*0.1081
I want to be certain I don't have prostate
cancer
-0.2802
-0.1573
*0.1265
-0.0083
I am very health conscious
-0.0620
*0.3413
-0.0210
0.0250
I am interested in men's health
-0.1999
-0.0082
0.1067
0.0985
I have a family history of prostate cancer
*0.1880
0.0352
0.1322
0.1357
*Strongest variables in each factor

A particular behavioral assessment will look at those who considered
themselves high risk and by looking at their family health history we can determine
what factors they consider to be threatening for prostate cancer incidence. For
example, in Chart 13, among total participants it is sensible that men who deemed
themselves high risk for prostate cancer had a relatively high incidence of prostate
cancer in their family, and primarily the incidence of prostate cancer in their father.
The incidence of diabetes in the family was the second most common family health
history factor in men who believe they are high risk for prostate cancer, a health
factor that has no proven health correlation with prostate cancer. (Perhaps the fact
that diabetes is associated with many other health problems is important here.)
Finally, although it is a variable for personal health and not family health- the factor
of participant’s smoking was assessed for those who considered themselves high
risk. The addition of a participant smoking variable proved to be a very strong
factor to men believing they are at high risk for prostate cancer. However, there is
no scientific basis for such a belief.
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Those African-American men who attended the screening did not have a high
incidence of family prostate cancer, but instead declared themselves high risk for
relatively high incidences of family history with diabetes and heart disease and if
they smoked (Chart 14). Smoking appears to have strong effect in men who
consider themselves high risk for prostate cancer for both African-American men
and also for the entire dataset.
There were seven variables that showed statistical difference in behavior
between returning versus new participants: These split variables between new and
returning participants all had a statistically significant mean difference with p-values
less than .05. Variables that have higher means show relevance to participants that
are new or returning. For example, new participants tend to have diets higher in fat,
tend to be smokers, have a higher BMI, think they are at high risk for prostate
cancer, and were encouraged by their wives to attend the screening. Men who
have had prostate infections and are interested in men’s health are more likely to be
returning participants.
Table 6: Relevant Behavioral and Medical Variables 2006-2008
Variable

P-Value

Higher Mean

Amount of diet in fat

0.003

New

Smoking

0.049

New

Prostate Infection

0.025

Returning

BMI

0.036

New

I think I am at High Risk for Prostate Cancer

0.006

New

My Wife Insisted I attend the Screening

0.002

New

I am Interested in Overall Men’s Health

0.049

Returning
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These variables indicate there are differences in the behavior between new and
returning participants and should therefore be placed into “participant model”
regressions for further differentiation between future new and returning participant
behavior.
B. BMI Test
BMI proves to be significantly different between all new and returning
participants, with a p-value of .036. In African-American men the variable also
proves worthy of further investigation between new and returning participants with
a p-value of .028<.05. Generally, new participants tend to have a higher BMI than
returning. This difference may have implications to participant lifestyle and health.
BMI may also have a relationship to other health variables assessed in participant
models.
Table 7: BMI Returning versus New Participant Difference 2006-2008
Variable
BMI All Data
BMI African-American men

P-Value
0.036
0.028

Higher Mean
New
New

C. Medical Factors
A look at a participant’s health regarding urinary, sexual, and testosterone
symptoms may indicate additional reasons for attendance. Each of these is
represented by a factor analysis, which indicates that all measures can be combined
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into a nearly equally-weighted index. Only one factor matters at all, unlike the
analysis of reasons for attendance, above. A specific t-test was performed for
urinary, sexual, and testosterone health symptoms and by converting t-test values to
p-values, we can look for variable relevance for those with p-values that are <.05.
Table 8: Health Symptoms New versus Returning Participant Difference 2006-2008
Variable

P-Value All Participants

P-Value African-American Men

Higher Mean

Urinary Health Problems

0.469

0.456

Returning

Sexual Health Problems

*0.014

*0.035

New

Testosterone Factors
*Results are relevant

*0.015

0.064

New

We can see that there are two variables that show significance, sexual health
symptoms and testosterone health symptoms. The results show that sexual and
testosterone health symptoms are more relevant to new participants and that men
with urinary health symptoms are more likely to be a returning participant. The
statistical analysis suggests no difference between these two groups on the urinary
variable. This is unfortunate, given that urinary health problems are much more
closely related to prostate cancer detection than the other two factors, sexual
health and testosterone problems (May Clinic, 2009).
D. Returning Participant Models
Using some of the relevant variables found in the foregoing analysis, a
participant model can be estimated for new and returning participants both for the
all participants and for African-American men specifically. Relevant medical
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variables used in the model were urinary, sexual health, and testosterone factors
and behavioral. The independent variables are: age, ethnicity, smoking, BMI, if they
considered themselves high risk, health conscious, if they were interested in overall
men’s health, and if their wife encouraged them to attend the screening as shown in
this regression and the dependent variable is if the participant was returning.
Table 9: Predictive Returning Participant Model
Variable
Coefficient
T-Test Value
P-Value
I consider myself health conscious
-0.168
-3.200
*0.001
Testosterone Health Symptoms
-0.052
-2.280
*0.023
Sexual Health Symptoms
-0.021
-1.120
0.262
I am interested in overall men’s health
-0.018
-0.240
0.808
My wife encouraged me to attend
-0.008
-0.070
0.941
Age
-0.003
-1.460
0.143
BMI
0.002
0.700
0.483
Urinary Health Symptoms
0.030
1.310
0.190
Smoking
0.078
2.070
*0.039
I think I am at high risk
0.114
2.560
*0.011
African-American Participant
0.087
1.110
0.268
*Negative Values= Unlikely returning
*Positive Values= Likely
participant behavior
behavior for returning participants
*Variables show relevance in model

Data with negative coefficients signify that the variable is unlikely behavior
for a returning participant, and variables with positive coefficients are behaviors that
are likely for returning participants. Further analysis will consider whether these
variables did have an impact by assessing their p-values. Men who consider
themselves health conscious and have testosterone health symptoms are less likely
to return and men who thought they were high risk or smoked were more likely to
return. Behavior variables that had proven significance in a participant not
returning was if they considered themselves health conscious (p-value of .001) and if
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they had testosterone health symptoms (p-value of .023). Variables that proved
significant for returning participants were if they thought they were at high risk (pvalue of .039) and if they smoked (p-value of .011).
This model may also educate program managers on other predictive
behaviors: smokers and high risk individuals being more likely to return, urinary
symptoms having no obvious effect on returning participants. For entire
participation, urinary health symptoms are showing no significance in future
program attendance.
Model 1 predicts the likely behavior that the majority of returning
participants will consider themselves high risk, and a significant portion will smoke.
This is possibly explained by positive relationship between those who consider
themselves high risk and who smoke. Note that these values don’t equal 1, but
instead represent a proportion of the found relevant behaviors. There may be
several behavioral variables that influence screening attendance that may be
unknown. The behavior of feeling at high risk was slightly more significant and
therefore may represent more of the population.
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Model 1: Likely Returning Predictive Behavior

Model 2 displays the unlikely characteristics of a returning participant’s
behavior. The majority of participants who don’t return tend to feel health
conscious, and about one-fourth are suffering from a loss of testosterone. Note that
these values don’t equal 1, but instead represent a proportion of the found relevant
behaviors. There may be several behavioral variables that influence screening
attendance that may be unknown. The behavior of feeling at health conscious was
substantially more significant and therefore may represent more of the population.
Model 2: Unlikely Returning Predictive Behavior
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African-American participant models can also be derived using similar variables that
may have significance on future African-American attendance:
Table 10: Predictive Returning Participant Model African-American Men
Variable
Coefficient
T-Test Value
P-Value
I consider myself health conscious
-0.266
-0.670
0.509
Urinary Health Symptoms
-0.096
-0.810
0.426
Sexual Health Symptoms
-0.248
-2.780
*0.009
Interested in overall men’s health
-0.188
-0.280
0.783
I think I am at high risk
-0.004
-0.010
0.989
Age
-0.011
-0.810
0.424
BMI
0.041
1.460
0.153
Testosterone Health Symptoms
0.167
2.030
*0.051
Smoking
0.090
0.480
0.632
My wife encouraged me to attend
0.068
0.090
0.930
*Negative Values= Unlikely returning
*Positive Values= Likely
behavior for returning participants
participant behavior
*Variables show relevance in model

Factors that predict African-American likely and unlikely returning behavior have
similar independent variables and the dependent variable. It is unlikely that a
returning African-American man is attending the screening because he is
encountering sexual health symptoms and it is likely that a returning participant is
encountering low testosterone symptoms. Urinary health symptoms are in fact,
showing no relationship for returning participation in future years. We can also infer
from the participant model that African-Americans are just as likely to return as
other participants, as there was no statistical significant difference. Since prostate
cancer is more likely for African-American men, equal participation can become a
problem.
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Models 3 and 4 both show that the likely and unlikely returning AfricanAmerican participant behavior is largely unknown. This may be reflective of the low
number of African-American screening participants. Model 3 predicts that returning
African-American men are somewhat of a mystery. However, nearly 1 in 5 are
suffering from a loss of testosterone. Note that these values don’t equal 1, but
instead represent a proportion of the found relevant behaviors. The behavior of
suffering from testosterone health symptoms held small significance, and there may
be untracked behavioral variables that influenced attendance.
Model 3: Likely Returning African-American Predictive Behavior

Model 4 predicts that nearly 25 precent of returning African-American men
aren’t suffering from sexual health symptoms, and a large portion of the population
is left unknown. Unknown behavior proves to be a difficulty in specifically increasing
this particular minority involvement. Note that these values don’t equal 1, but
instead represent a proportion of the found relevant behaviors. The behavior of
suffering from sexual health symptoms held small significance, and there may be
untracked behavioral variables that influenced attendance.
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Model 4: Unlikely Returning African-American Predictive Behavior

E. Study Limitations
Screening anxiety is a strong behavioral factor that may affect participant’s
attendance and is not assessed in the study. Previous studies assessing anxiety as a
component of prostate cancer have been inconclusive. Although studies have
shown that the screening does not seem to cause any major psychological distress in
the majority of men, it is to be expected that a higher level of psychological distress
has been observed in those who screen positive (Carlsoon, 2007). The fear of a
positive test could hinder attendance rates, and this could be a factor in the
apparent tendency of those with worse health habits to avoid returning.
Other program initiatives are to teach and educate participants about
prostate cancer and prostate health, and to recommend follow-up if needed. The
research failed to provide information as to whether participants are learning about
prostate cancer health and its warning signs. The single largest factor derived from
reasons for participation is high risk or family history with a desire for certainty,
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which indicates some knowledge of the medical issues. There are other factors, and
those attending for other reasons could be educated about prostate cancer.
The amendment of the survey year after year proves very difficult in
accurately coding variables and in maintaining consistency in the program. Some
relevant variables to determine the program’s mission were dropped after 2006. It
was very helpful for the PCEC to maintain consistency in the program questionnaire
and to code variables similarly year after year. The survey also tracked amount of
knowledge program participants have about prostate cancer. At only one time did
the study ask the question, and therefore it was thrown out due to the extremely
limited responses. This question should be asked on future questionnaires, as
education is an important part of the program’s mission. It would have been nice to
analyze more data than that of a three year period. Data should have been available
from 2003-2008, but the PCEC had misplaced 2005 data. It also would have been a
more conclusive study to look at data from other PCEC screening sites within the
state of Kentucky.
Variables that may have been significant were eliminated from analyses as
they were incomplete. Questionnaires failed to track variables such as the relevant
“other” category on method of learning about the program, and the “work” variable
wasn’t captured in 2006 at all. I anticipate the “work” variable would have more
significance with complete data.
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IV. Conclusion and Recommendations
Prostate Cancer Screening serves as an effective means of early detection as
backed by numerous literature and research sources. The data presented shows an
effective means of generalizing participant behavior and those factors which
influence medial attendance. Participant models should help program managers
understand their served populations. The findings from the study may help program
managers market the program more effectively and more efficiently.
Certain variables have more relevance in screening attendance than others.
Variables that had some behavioral and medical significance were: smoking, diet in
fat, BMI, urinary, testosterone and sexual health symptoms, and if the participants
were health conscious or not. Variables that showed significant difference between
likely and unlikely returning participant behavior were placed into participant
models to predict whether or not they will return. These participant models may be
useful to program managers in understanding screening participant behaviors and to
help target program marketing efforts to encourage retention.
Participant models generally showed that returning participants believed
they were at high risk for prostate cancer, and tended to smoke. However, the
program seems to discourage retention of men who are self-declared health
conscious and who may be suffering from a loss of testosterone. Program managers
should work on recruiting and retaining men with these behaviors. It is good that
men at high risk are attracted to the program, but other groups can be targeted
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more specifically: those who are generally health conscious, and wives of men who
are not! It would be helpful for program manager’s to use participant model
concepts to continue to predict behavior, and to apply these methods to other
cancer screening programs.
It is also important for program managers to notice the decrease in
participation for this three-year period. As this is a grant-funded program,
attendance is imperative to its survival. A marketing plan should be put in place to
increase participation in the upcoming years. Currently, the most effective
marketing method is word of mouth via friends and family and the use of newspaper
ads for new participants. There are two marketing methods that should be
explored. New participants can be recruited by advertising on the radio or
television, and returning participants should be sought at places of work.
The internet proved to have nearly no impact, which clearly needs to be
addressed as it has become a critical marketing tool in the 20th century. Known for
its ability to provide inexpensive advertising, all avenues of internet marketing are
feasible. Marketing via www.uky.edu/healthcare should be explored.
African-American participation has also decreased in this three-year period.
Because program initiatives focus on increasing minority participation and their
higher incidence of prostate cancer, program managers should pay special attention
to under-utilized marketing methods. To target the African-American population
program specifically, managers should look at reaching out to potential places of
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employment. Other successful marketing mediums were also the newspapers and
on radio and television.
Despite the smaller sample size available, results indicated that sexual health
problems attracted African-Americans to the program, but proved to be an unlikely
behavior for a returning participant. This suggests both a means of advertising that
might work and the need to emphasize that urinary problem symptoms are also a
reason to participate, and in fact may be medically more relevant.
Although predictions for African-American men are largely unknown, these
models do show two relevant likely and unlikely behaviors for returning men. If
there is a likely predictive behavior, a minority of new African-American men will be
suffering from a loss of testosterone, and it is unlikely that returning AfricanAmerican men will be suffering from sexual health symptoms. These two specific
behaviors tell managers that to increase the African-American participation specific
marketing methods should target these symptoms.
It appears that men in general aren’t educated on the relation of urinary
symptoms to that of prostate cancer as explained by the National Kidney and
Urologic Disease Information Clearinghouse. It’s unfortunate that urinary symptoms
played a nominal role in participation attendance. Instead men are more likely to be
suffering from sexual health problems, and therefore relating these symptoms to
the potential that they may have prostate cancer.
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VI. Appendices: Charts and Tables
Chart 5: Participant’s Diet in Fat 2006-2008

*Source: PCEC 2008

Chart 6: African-American Participant’s Diet in Fat 2006-2008

*Source: PCEC 2008
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Chart 7: Participant’s Incidence of Smoking 2006-2008

*Source: PCEC 2008

Chart 8: Participant’s Incidence of Smoking African-American Men 2006-2008

*Source: PCEC 2008
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Chart 9: Participant’s Amount of Exercise 2006-2008

*Source: PCEC 2008

Chart 10: Amount of Exercise African-American Men 2006-2008

*Source: PCEC 2008
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Chart 11: Participant’s Health Conditions 2006-2008

*Source: PCEC 2008
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Chart 12: Participant’s Health Conditions African-American Men 2006-2008

*Source: PCEC 2008
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Chart 13: Participant’s Health History- High Risk 2006-2008

*Diabetes, Heart Disease and Lung Cancer were tracked in 2007 and 2008 only

*Source: PCEC 2008
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Chart 14: Health History African-American Men- High Risk 2006-2008

*Diabetes, Heart Disease and Lung Cancer were tracked in 2007 and 2008 only

*Source: PCEC 2008
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Chart 15: Participant Reason Attended 2006-2008

*Source: PCEC 2008

Chart 16: African-American Participant’s Reason for Attending 2006-2008

*Source: PCEC 2008
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Chart 17: New Program Participants: Reason Attended 2006-2008

*Source: PCEC 2008

Table 11: Factor Analysis Pattern Matrix, Urinary Symptoms:
Variable
Sensation of not emptying your bladder
How have have you had to urinate?
How often have you found you stopped and started?
How often have you found it difficult to postpone?
How often have you had a weak urinary stream?
How often do you push or strain to begin urination?
How many times do you get up to urinate at night?
How would you feel about your urinary condition?
*Results are relevant

Factor 1
Factor 2
Factor 3
*0.7794
-0.104
-0.1218
*0.7309
0.1731
-0.0586
*0.7887
-0.1496
-0.0760
*0.7117
0.1554
840
*0.7574
-0.1483
0.0765
*0.7377
-0.1501
0.1212
*0.5918
0.1916
0.0644
*0.5902
0.1212
-0.0805
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Table 12: Factor Analysis Pattern Matrix, Sexual Health Symptoms:
Variable

Factor 1

Factor 2

Factor 3

How do you rate your confidence that you could get
and keep an erection?

*0.6619

0.0775

0.0393

When you had erections, how often were they hard
enough for penetration?
How often were you abot to maintain your erection?

*0.8698
*0.9195

0.1186
0.0476

-0.0122
-0.0254

*0.9132
*0.8905

-0.0917
-0.01286

0.0189
-0.0105

How difficult was it to maintain your erection to
completion?
How often was intercourse satisfactory to you?
*Results are relevant

Table 13: Factor Analysis Pattern Matrix, Testosterone Health Symptoms:
Variable
Do you have a decrease in libido?
Do you have a lack of energy?

Factor 1
Factor 2
Factor 3
*0.8986
0.1898
0.1118
*0.9307
0.0505
-0.1439

Do you have a decrease in strength and/or
endurance?
Have you lost height?
Have you noticed a decreased "enjoyment in life"?
Are you sad and/or grumpy?
Are your erections less strong?

*0.9075
*0.9186
*0.9459
*0.9441
*0.8414

0.1444
-0.1087
-0.1734
-0.1807
0.2381

-0.1505
0.0377
0.0404
0.0522
0.1256

Have you noticed a recent deteroriation in your
ability to play sports?
Are you falling asleep after dinner?

*0.9089
*0.9068

0.0302
-0.0349

-0.0759
0.0271

*0.9568

-0.1153

-0.0139

Have there been a recent deterioration in your work
performance?
*Results are relevant
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